In a complex legal matter involving Edwards Lifesciences Corporation and Meril Life Sciences, along with other associated entities, the Nordic-Baltic Regional Division of the Unified Patent Court issued a decision primarily addressing applications for withdrawal and confidentiality related to cost decisions. Various proceedings were connected to the patent EP 3 769 722 B1, initially involving infringement and counterclaims for revocation.

Both parties agreed to withdraw their applications for cost decisions, but maintained confidentiality requests, which the Court approved, thereby declaring the proceedings closed. The Court ordered specific sections of the applications and exhibits to be treated as confidential, prohibiting their disclosure to third parties. Consequently, the proceedings were registered as closed, fulfilling the parties' requests and maintaining confidentiality terms even post-proceedings.